公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2011 | Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma | Guan B.; TSUI-LIEN MAO ; Panuganti P.K.; Kuhn E.; Kurman R.J.; Maeda D.; Chen E.; YUNG-MING JENG ; Wang T.-L.; Shih I.-M. | American Journal of Surgical Pathology | 229 | 213 | |
2021 | Pembrolizumab as second-line therapy for advanced hepatocellular carcinoma: A subgroup analysis of asian patients in the phase 3 KEYNOTE-240 trial | Kudo M.; Lim H.Y.; ANN-LII CHENG ; Chao Y.; Yau T.; Ogasawara S.; Kurosaki M.; Morimoto N.; Ohkawa K.; Yamashita T.; Lee K.-H.; Chen E.; Siegel A.B.; Ryoo B.-Y. | Liver Cancer | 30 | 26 | |
2020 | Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYnote-240: A Randomized, Double-Blind, Phase III Trial | Finn R.S.; Ryoo B.-Y.; Merle P.; Kudo M.; Bouattour M.; Lim H.Y.; Breder V.; Edeline J.; Chao Y.; Ogasawara S.; Yau T.; Garrido M.; Chan S.L.; Knox J.; Daniele B.; Ebbinghaus S.W.; Chen E.; Siegel A.B.; Zhu A.X.; ANN-LII CHENG ; KEYnote-240 investigators | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 1188 | 1028 | |
2013 | Predictive factors for overall quality of life in patients with advanced cancer | Cramarossa G.; Chow E.; Zhang L.; Bedard G.; Zeng L.; Sahgal A.; Vassiliou V.; Satoh T.; Foro P.; Ma B.B.Y.; WEI-CHU CHIE ; Chen E.; Lam H.; Bottomley A. | Supportive Care in Cancer | 53 | 49 |